Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Filippo Martone"'
Autor:
Robert P. Baughman, Rita Barriuso, Kelli Beyer, Jeanette Boyd, Johann Hochreiter, Chris Knoet, Filippo Martone, Bernd Quadder, Jack Richardson, Ginger Spitzer, Dominique Valeyre, Gianluca Ziosi
Publikováno v:
ERJ Open Research, Vol 4, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/04187f017bea4d4eba56d8c98f416a54
Autor:
Jan C. Grutters, Alexander G. Mathioudakis, Ginger Spitzer, Bernd Quadder, Marc A. Judson, Daniel A. Culver, Thomy Tonia, Elyse E. Lower, Robert P. Baughman, Peter Korsten, Francesco Bonella, Athol U. Wells, Dominique Israël-Biet, Dominique Valeyre, Katerina M. Antoniou, Hiliaro Nunes, Daniel R. Ouellette, Filippo Martone, Marjolein Drent, Wim A. Wuyts, David Rigau, Paola Rottoli, Blin Nagavci
Publikováno v:
EUROPEAN RESPIRATORY JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Respiratory Journal, 58(6):2004079. European Respiratory Society
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Respiratory Journal, 58(6):2004079. European Respiratory Society
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality risk or to improve quality of life (QoL). The indication for treatment varies depending on which manifestation is the cause of symptoms: lungs, heart, brain, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::972ec1de2a247f10f41d992f3f3b658d
https://doi.org/10.1183/13993003.04079-2020
https://doi.org/10.1183/13993003.04079-2020
Autor:
Jeanette Boyd, Jack Richardson, Robert P. Baughman, Johann Hochreiter, Ginger Spitzer, Dominique Valeyre, Rita Barriuso, Chris Knoet, Filippo Martone, Gianluca Ziosi, Bernd Quadder, Kelli Beyer
Publikováno v:
ERJ Open Research, Vol 4, Iss 4 (2018)
ERJ Open Research
ERJ Open Research
Sarcoidosis is a rare disease with the number of patients in the European Union (28 member states), Norway, Iceland and Lichtenstein estimated as ∼102 000 [1, 2]. Some 40% of individuals experience sarcoidosis as a chronic condition, while >60% of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33a9b9728f3f00904973df4854a1641e
http://openres.ersjournals.com/content/4/4/00141-2018.full
http://openres.ersjournals.com/content/4/4/00141-2018.full
Autor:
Dorrit Irène Novel, Chris Knoet, Ginger Spitzer, Robert P. Baughman, Jeanette Boyd, Gianluca Ziosi, Jack Richardson, Linda Charvoz, Filippo Martone, Johanna Hochreiter, Dominique Valeyere, Hanns-Peter Faber, Bernd Quadder, Ana Rosa Álvarez Rodríguez
Publikováno v:
Sarcoidosis and other granulomatous ILD/DPLD.
Purpose of Study: A sarcoidosis treatment guidleine is being developed by a European Respiratory Society (ERS) working group. The sarcoidosis support groups were asked to provide input regarding what outcomes were most important to the patient. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a79c7d3f3247fe7b7da108258965d162
https://doi.org/10.1183/13993003.congress-2018.pa5219
https://doi.org/10.1183/13993003.congress-2018.pa5219
Publikováno v:
The Journal of prosthetic dentistry. 80(4)
Statement of problem. In many situations, provisional restorations require a long-term permanence in the oral cavity. During this period, the abutments need the best possible biologic and mechanical protection. In this way, the vitality of the pulp a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0567160d521b77a379af7a324f8bfa
https://pubmed.ncbi.nlm.nih.gov/9791787
https://pubmed.ncbi.nlm.nih.gov/9791787